Viridian Therapeutics
VRDN
VRDN
46 hedge funds and large institutions have $25M invested in Viridian Therapeutics in 2019 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 12 closing their positions.
Holders
46
Holders Change
-5
Holders Change %
-9.8%
% of All Funds
1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
10
Reduced
14
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Millennium Management
New York
|
$1.22M |
| 2 |
2
Goldman Sachs
New York
|
$1.12M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$1.27M |
| 4 |
PP
4
Paloma Partners
Greenwich,
Connecticut
|
$239K |
| 5 |
5
Jane Street
New York
|
$159K |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
New York State Common Retirement Fund
Albany,
New York
| – | – | -28,400 | Closed |
|
|
AIG
52
American International Group
New York
| – | – | -16,576 | Closed |
|
53
Acadian Asset Management
Boston,
Massachusetts
| – | – | -12,972 | Closed |
|
54
VOYA Investment Management
Atlanta,
Georgia
| – | – | -10,551 | Closed |
|
|
FAM
55
Formidable Asset Management
Cincinnati,
Ohio
| – | – | -7,790 | Closed |
|
|
AIP
56
Ameritas Investment Partners
Lincoln,
Nebraska
| – | – | -1,109 | Closed |
|
|
CFGS
57
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
58
UBS Group
Zurich,
Switzerland
| $0 | 274 | +74 | +37% |
|
|
PHK
59
Point72 Hong Kong
Hong Kong
| $0 | 193 | +193 | New |
|